Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Efficacy and Safety of AN2690 Topical Solution to Treat Onychomycosis of the Toenail

ClinicalTrials.gov ID: NCT01302119

Public ClinicalTrials.gov record NCT01302119. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 1:49 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Vehicle-Controlled, Multi-Center Study to Evaluate the Efficacy and Safety of AN2690 Topical Solution, 5%, vs. Solution Vehicle in the Treatment of Onychomycosis of the Toenail in Adults

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to determine whether AN2690 topical solution is a safe and effective treatment for onychomycosis of the toenail.

Study identification

NCT ID
NCT01302119
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Pfizer
Industry
Enrollment
604 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 2011 (Type not available)
Primary completion
Dec 31, 2012 (Actual)
Completion
Feb 20, 2013 (Actual)
Last update posted
Apr 3, 2019

2011 – 2013

United States locations

U.S. sites
26
U.S. states
18
U.S. cities
25
Facility City State ZIP Site status
Investigational Site Phoenix Arizona 85050 —
Investigational Site Novato California 94945 —
Investigational Site Oceanside California 92056 —
Investigational Site San Diego California 92123 —
Investigational Site San Francisco California 94115 —
Investigational Site Santa Rosa California 95405 —
Investigational Site Miami Florida 33144 —
Investigational Site Miami Florida 33175 —
Investigational Site Nampa Idaho 83642 —
Investigational Site Evansville Indiana 47714 —
Investigational Site Ann Arbor Michigan 48103 —
Investigational Site St Louis Missouri 63117 —
Investigational Site Verona New Jersey 07044 —
Investigational Site Albuquerque New Mexico 87106 —
Investigational Site High Point North Carolina 27262 —
Investigational Site Raleigh North Carolina 27612 —
Investigational Site Columbus Ohio 43212 —
Investigational Site Portland Oregon 97223 —
Investigational Site Philadelphia Pennsylvania 19103 —
Investigational Site Greer South Carolina 29651 —
Investigational Site Knoxville Tennessee 37922 —
Investigational Site Dallas Texas 75243 —
Investigational Site San Antonio Texas 78209 —
Investigational Site Salt Lake City Utah 84124 —
Investigational Site Harrisonburg Virginia 22801 —
Investigational Site Norfolk Virginia 23507 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 6 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01302119, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 3, 2019 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01302119 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →